Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

1.44
BATS BZX Real-Time Price
As of 2:58pm ET
 +0.06 / +4.35%
Today’s Change
1.29
Today|||52-Week Range
8.50
-69.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-11.8M-21.7M-27.2M-44.3M
 
 
 
 
 
Depreciation89.0K132.0K249.0K293.0K
 
 
 
 
 
Total Other Cash Flow2.0M1.3M2.6M4.7M
 
 
 
 
 
Funds From Operations-9.6M-20.3M-24.4M-39.4M
 
 
 
 
 
Funds From/For Other Operating Expenses1.3M-1.5M198.0K-7.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-11.0M-18.8M-24.6M-32.2M
 
 
 
 
 
 
InvestingIncrease In Investments-3.8M-20.4M-64.1M-62.2M
 
 
 
 
 
Decrease In Investments0.008.4M42.2M47.4M
 
 
 
 
Capital Expenditures-208.0K-212.0K-619.0K-422.0K
 
 
 
 
 
Net Cash Flow Investing-4.0M-12.2M-22.5M-15.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale41.7M49.4M12.2M57.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends--0.000.000.00--
Cash Dividends Paid - Total--0.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing41.7M49.4M12.2M57.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash26.7M18.4M-34.9M9.6M